Farnsworth David E. sold (to issuer) 16,275 shares of MRCY

Farnsworth David E. (EVP, CFO) sold (to issuer) 16,275 shares of MERCURY SYSTEMS INC (MRCY) on 2026-08-14.

Original reporting
SEC EDGAR · Farnsworth David E.
Published Aug 18, 2026, 10:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 11:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MRCY
Neutral
medium confidence
Mentioned
$MRCY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MRCYNeutralLow
01

Why it matters

The filing updates insider ownership (post-transaction holdings 141,426 shares) but does not provide a fundamental driver like guidance, contracts, or regulatory actions.

02

Market read

Traders may monitor insider activity, but this specific disclosure lacks sale price/value and does not indicate a new corporate catalyst.

03

What to watch

The transaction is coded as sale to the issuer (often buyback participation or similar mechanics), and the price and total value are not disclosed, reducing interpretability.

Relevance 3/10Novelty 3/10Timing: filed after-hours on 2026-08-18, covering a 2026-08-14 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Mercury Systems Inc.

Company-level read

Ticker impact

$MRCYNeutralMedium confidence
Context

MRCY disclosed CFO David Farnsworth sold 16,275 shares to the issuer on 2026-08-14, with price not disclosed.

Expected impact

Likely limited near-term impact; any reaction would be small and short-lived unless paired with other news.

Evidence & confidence

Form 4 insider transactions are typically low-signal for fundamentals, and the filing provides no sale price, value, or accompanying corporate event.

Market effects

No sector-level read-through is provided beyond a single insider transaction.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.

Key entities

  • MERCURY SYSTEMS INC

    Company whose CFO insider sale to the issuer was reported on Form 4.

  • Farnsworth David E.

    EVP, CFO who sold 16,275 shares to the issuer on 2026-08-14.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MRCYHighAI 8/10

Mercury Systems earnings analysis: questions answered and next catalysts

Mercury Systems (MRCY) reported Q1 2027 earnings with adjusted EPS of $0.52, beating estimates by 73%, and revenue of $253.0M, up 12.4% organically. The stock rose 5% to $83.58 post-earnings and is now at $87.25. Management raised FY2027 targets, including revenue approaching $1.1B and adjusted EBITDA of ~$210M. Key questions remain around cash flow, margin durability, and supply chain bottlenecks.

$MRCYHighAI 8/10

Mercury Systems (MRCY) Q1 2027 Earnings Call Transcript

Mercury Systems (MRCY) reported Q1 FY '27 record bookings ($370M, +48% YoY), revenue ($253M), and adjusted EBITDA ($56M). The company raised its FY '27 outlook, expecting double-digit revenue growth and $1.1B in total revenue. Key growth drivers include increased production volumes and defense spending tailwinds. The company also highlighted progress in margin expansion and free cash flow conversion.

$MRCYHighAI 8/10

Why is Mercury Systems stock rallying today?

Mercury Systems (MRCY) stock rose 3.8% after reporting fiscal Q1 earnings that surpassed estimates, with adjusted EPS of $0.52 vs. $0.30 and revenue of $253M vs. $245M. JPMorgan upgraded the stock to Overweight with a $102 target, citing strong bookings and backlog growth. Piper Sandler reiterated its Overweight rating with a $107 target. The company's record Q1 bookings of $370M and a total backlog of $2.1B highlighted robust defense demand.

$MRCYMed

JPMorgan upgrades this aerospace stock after earnings beat

JPMorgan upgraded Mercury Systems (MRCY) to overweight, citing strong Q1 earnings and revenue beats. The bank lowered its price target to $102 but sees 22% upside. Mercury raised its full-year adjusted EBITDA and revenue growth outlook, with a 35.2% gross margin, the highest since Q2 2023, according to JPMorgan.